blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3608419

EP3608419 - BIOMARKER FOR USE IN TREATING ANEMIA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.02.2026
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  21.02.2025
FormerGrant of patent is intended
Status updated on  21.10.2024
FormerExamination is in progress
Status updated on  11.05.2021
FormerRequest for examination was made
Status updated on  14.08.2020
FormerThe application has been published
Status updated on  10.01.2020
Most recent event   Tooltip06.02.2026No opposition filed within time limitpublished on 11.03.2026  [2026/11]
Applicant(s)For all designated states
Celgene Corporation
Route 206 & Province Line Road
Princeton, NJ 08543 / US
[2024/14]
Former [2020/07]For all designated states
Celgene Corporation
86 Morris Avenue
Summit, NJ 07901 / US
Inventor(s)01 / SUNG, Victoria
1529 Oak St.
San Francisco, CA 94117 / US
02 / CHOPRA, Rajesh
Flat 5 Ruvigny Mansions
Embankment, Putney
London SW15 1LE / GB
03 / HERMINE, Olivier
127 Avenue du Général Leclerc
91120 Palaiseau / FR
04 / CRUZ MOURA, Ivan
43, rue Fondary
75015 Paris / FR
05 / DUSSIOT, Michael
15 Rue Gabriel Peri
92320 Chatillon / FR
06 / TROVATI MACIEL, Thiago
42 avenue du Marechal de Turenne (Bat.A1)
94290 Villeneuve le Roi / FR
07 / FRICOT, Aurelie
29, Rue des Deux Communes
93100 Montreuil / FR
 [2020/07]
Representative(s)Jones Day
Gewürzmühlstr. 11
80538 München / DE
[N/P]
Former [2020/07]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
Application number, filing date19184182.423.10.2013
[2020/07]
Priority number, dateUS201261718126P24.10.2012         Original published format: US 201261718126 P
[2020/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3608419
Date:12.02.2020
Language:EN
[2020/07]
Type: B1 Patent specification 
No.:EP3608419
Date:26.03.2025
Language:EN
[2025/13]
Search report(s)(Supplementary) European search report - dispatched on:EP17.12.2019
ClassificationIPC:C12Q1/68, G01N33/53, G01N33/68, C07K14/705, G01N33/72, G01N33/74
[2020/07]
CPC:
A61K38/179 (EP,IL,US); G01N33/74 (IL,US); A61P7/00 (EP,IL,US);
A61P7/06 (EP,IL,US); C07K14/705 (IL,US); C07K14/71 (EP,IL,US);
C12Q1/6883 (IL,US); G01N33/6893 (EP,IL,US); G01N33/721 (EP,IL,US);
C07K2319/30 (EP,IL,US); C12Q2600/158 (IL,US); G01N2333/51 (EP,IL,US);
G01N2800/52 (IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/38]
Former [2020/07]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:BIOMARKER ZUR VERWENDUNG BEI DER BEHANDLUNG VON ANÄMIE[2020/07]
English:BIOMARKER FOR USE IN TREATING ANEMIA[2020/07]
French:BIOMARQUEUR UTILISABLE DANS LE TRAITEMENT DE L'ANÉMIE[2020/07]
Examination procedure12.08.2020Amendment by applicant (claims and/or description)
12.08.2020Examination requested  [2020/38]
12.08.2020Date on which the examining division has become responsible
10.05.2021Despatch of a communication from the examining division (Time limit: M04)
17.09.2021Reply to a communication from the examining division
22.03.2023Despatch of a communication from the examining division (Time limit: M04)
27.07.2023Reply to a communication from the examining division
22.10.2024Communication of intention to grant the patent
19.02.2025Fee for grant paid
19.02.2025Fee for publishing/printing paid
19.02.2025Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP13848471.2  / EP2912462
Opposition(s)05.01.2026No opposition filed within time limit [2026/11]
Fees paidRenewal fee
03.07.2019Renewal fee patent year 03
03.07.2019Renewal fee patent year 04
03.07.2019Renewal fee patent year 05
03.07.2019Renewal fee patent year 06
10.10.2019Renewal fee patent year 07
14.10.2020Renewal fee patent year 08
19.10.2021Renewal fee patent year 09
15.09.2022Renewal fee patent year 10
13.09.2023Renewal fee patent year 11
12.09.2024Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.03.2025
BG26.03.2025
CZ26.03.2025
DK26.03.2025
EE26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
PL26.03.2025
RO26.03.2025
SE26.03.2025
SK26.03.2025
SM26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
IS26.07.2025
PT28.07.2025
[2026/09]
Former [2026/08]AT26.03.2025
BG26.03.2025
DK26.03.2025
EE26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
PL26.03.2025
RO26.03.2025
SE26.03.2025
SK26.03.2025
SM26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
IS26.07.2025
PT28.07.2025
Former [2025/49]AT26.03.2025
BG26.03.2025
EE26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
PL26.03.2025
RO26.03.2025
SE26.03.2025
SK26.03.2025
SM26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
IS26.07.2025
PT28.07.2025
Former [2025/48]AT26.03.2025
BG26.03.2025
EE26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
PL26.03.2025
SE26.03.2025
SM26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
PT28.07.2025
Former [2025/47]BG26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
PL26.03.2025
SE26.03.2025
SM26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
PT28.07.2025
Former [2025/46]BG26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
SE26.03.2025
SM26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
PT28.07.2025
Former [2025/42]BG26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
SE26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
Former [2025/39]BG26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NL26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
Former [2025/35]BG26.03.2025
FI26.03.2025
HR26.03.2025
LV26.03.2025
NO26.06.2025
RS26.06.2025
GR27.06.2025
Former [2025/34]FI26.03.2025
HR26.03.2025
LV26.03.2025
NO26.06.2025
RS26.06.2025
Former [2025/33]FI26.03.2025
RS26.06.2025
Documents cited:Search[A] WO2011020045  (ACCELERON PHARMA INC et al.)
 [A] WO2009158025  (ACCELERON PHARMA INC et al.)
 [A] US2012237521  (BERGER CATRIN et al.)
 [IP]   DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 16 November 2012 (2012-11-16), CARRANCIO SORAYA ET AL: "Sotatercept, an Activin Receptor IIa Ligand Trap, Acts Through Bone Marrow Accessory Cells to Promote Late-Stage Erythropoiesis and a Rapid Induction of Red Blood Cell Number and Hemoglobin", XP002757056, Database accession no. PREV201300232414
by applicantUS201261718126
 WO02088171
 WO2006055689
 WO0232925
 WO2005037989
 US2003133939
 US2005238646
 WO8705330
 US5223409
 US5198346
 US5096815
 US2009005308
 US2010068215
 WO2006012627
 WO2010019261
 WO2008030367
 WO2005025601
 US6537966
   MATHEWSVALE, CELL, vol. 65, 1991, pages 973 - 982
   ATTISANO ET AL., CELL, vol. 68, no. 1, 1992, pages 97 - 108
   YAMASHITA ET AL., J. CELL BIOL., vol. 130, 1995, pages 217 - 226
   LEEMCPHERRON, PROC. NATL. ACAD. SCI., vol. 98, 2001, pages 9306 - 9311
   YEOWHITMAN, MOL. CELL, vol. 7, 2001, pages 949 - 957
   OH ET AL., GENES DEV, vol. 16, 2002, pages 2749 - 54
   SKOW LC ET AL., CELL, vol. 34, 1983, pages 1043 - 52
   JACOBS ET AL., NEPHROL DIAL TRANSPLANT, vol. 15, 2000, pages 15 - 19
   SOUZA ET AL., MOL. ENDOCRINOLOGY, vol. 22, no. 12, 2008, pages 2689 - 2702
   BESSA ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 63, 2009, pages 89 - 94
   APLINWRISTON, CRC CRIT. REV. BIOCHEM., 1981, pages 259 - 306
   HAKIMUDDIN ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 259, 1987, pages 52
   EDGE ET AL., ANAL. BIOCHEM., vol. 118, 1981, pages 131
   THOTAKURA ET AL., METH. ENZYMOL., vol. 138, 1987, pages 350
   NARANG, S A, TETRAHEDRON, vol. 39, 1983, pages 3
   FRALEY ET AL., TRENDS BIOCHEM. SCI., vol. 6, 1981, pages 273 - 289
   ITAKURA ET AL., ANNU. REV. BIOCHEM., vol. 53, 1984, pages 323
   ITAKURA ET AL., SCIENCE, vol. 198, 1984, pages 1056
   IKE ET AL., NUCLEIC ACID RES., vol. 11, 1983, pages 477
   DEVLIN ET AL., SCIENCE, vol. 249, 1990, pages 404 - 406
   ROBERTS ET AL., PNAS USA, vol. 89, 1992, pages 2429 - 2433
   CWIRLA ET AL., PNAS USA, vol. 87, 1990, pages 6378 - 6382
   RUF ET AL., BIOCHEMISTRY, vol. 33, 1994, pages 1565 - 1572
   WANG ET AL., J. BIOL. CHEM., vol. 269, 1994, pages 3095 - 3099
   BALINT ET AL., GENE, vol. 137, 1993, pages 109 - 118
   GRODBERG ET AL., EUR. J. BIOCHEM., vol. 218, 1993, pages 597 - 601
   NAGASHIMA ET AL., J. BIOL. CHEM., vol. 268, 1993, pages 2888 - 2892
   LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10838
   CUNNINGHAM ET AL., SCIENCE, vol. 244, 1989, pages 1081 - 1085
   GUSTIN ET AL., VIROLOGY, vol. 193, 1993, pages 653 - 660
   BROWN ET AL., MOL. CELL BIOL, vol. 12, 1992, pages 2644 - 2652
   MCKNIGHT ET AL., SCIENCE, vol. 232, 1982, pages 316
   MEYERS ET AL., SCIENCE, vol. 232, 1986, pages 613
   LEUNG ET AL., METHOD CELL MOL BIOL, vol. 1, 1989, pages 11 - 19
   BROWN ET AL., MOL. CELL BIOL., vol. 12, 1992, pages 2644 - 2652
   GREENER ET AL., STRATEGIES IN MOL BIOL, vol. 7, 1994, pages 32 - 34
   GOEDDEL: "Gene Expression Technology: Methods in Enzymology", 1990, ACADEMIC PRESS
   "Molecular Cloning A Laboratory Manual", 2001, COLD SPRING HARBOR LABORATORY PRESS
   HOCHULI ET AL., J. CHROMATOGRAPHY, vol. 411, 1987, pages 177
   JANKNECHT ET AL., PNAS USA, vol. 88, pages 8972
   DEL RE ET AL., J BIOL CHEM., vol. 279, no. 51, 17 December 2004 (2004-12-17), pages 53126 - 35
   HILDEN ET AL., BLOOD, vol. 83, no. 8, 1994, pages 2163 - 70
   BIOCHEMISTRY, vol. 33, pages 1565 - 1572
   MANNINO ET AL., BIOTECHNIQUES, vol. 6, 1988, pages 682
   KOHLERMILSTEIN, NATURE, vol. 256, 1975, pages 495 - 497
   KOZBAR ET AL., IMMUNOLOGY TODAY, vol. 4, 1983, pages 72
   COLE ET AL.: "Monoclonal Antibodies and Cancer Therapy", 1985, ALAN R. LISS, INC, pages: 77 - 96
   WU HLIU XJAENISCH RLODISH HF: "Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor", CELL, vol. 83, no. 1, 1995, pages 59 - 67
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.